258 related articles for article (PubMed ID: 29596797)
1. Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin.
Huang Y; Cao S; Zhang Q; Zhang H; Fan Y; Qiu F; Kang N
Arch Biochem Biophys; 2018 May; 646():31-37. PubMed ID: 29596797
[TBL] [Abstract][Full Text] [Related]
2. Curcumin analogues and their hybrid molecules as multifunctional drugs.
Noureddin SA; El-Shishtawy RM; Al-Footy KO
Eur J Med Chem; 2019 Nov; 182():111631. PubMed ID: 31479974
[TBL] [Abstract][Full Text] [Related]
3. Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets.
Chainoglou E; Hadjipavlou-Litina D
Expert Opin Drug Discov; 2019 Aug; 14(8):821-842. PubMed ID: 31094233
[No Abstract] [Full Text] [Related]
4. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
Teymouri M; Barati N; Pirro M; Sahebkar A
J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095
[TBL] [Abstract][Full Text] [Related]
5. Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities.
Yen FL; Wu TH; Tzeng CW; Lin LT; Lin CC
J Agric Food Chem; 2010 Jun; 58(12):7376-82. PubMed ID: 20486686
[TBL] [Abstract][Full Text] [Related]
6. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives.
Xu XY; Meng X; Li S; Gan RY; Li Y; Li HB
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30347782
[TBL] [Abstract][Full Text] [Related]
7. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.
Ireson C; Orr S; Jones DJ; Verschoyle R; Lim CK; Luo JL; Howells L; Plummer S; Jukes R; Williams M; Steward WP; Gescher A
Cancer Res; 2001 Feb; 61(3):1058-64. PubMed ID: 11221833
[TBL] [Abstract][Full Text] [Related]
8. Curcumin: a boon to colonic diseases.
Sareen R; Jain N; Pandit V
Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
[TBL] [Abstract][Full Text] [Related]
9. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs).
Zhao C; Liu Z; Liang G
Curr Pharm Des; 2013; 19(11):2114-35. PubMed ID: 23116317
[TBL] [Abstract][Full Text] [Related]
10. Diverse Effects of Different "Protein-Based" Vehicles on the Stability and Bioavailability of Curcumin: Spectroscopic Evaluation of the Antioxidant Activity and Cytotoxicity In Vitro.
Mirzaee F; Hosseinzadeh L; Ashrafi-Kooshk MR; Esmaeili S; Ghobadi S; Farzaei MH; Zad-Bari MR; Khodarahmi R
Protein Pept Lett; 2019; 26(2):132-147. PubMed ID: 30430934
[TBL] [Abstract][Full Text] [Related]
11. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
12. Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress.
Martinez-Cifuentes M; Weiss-Lopez B; Santos LS; Araya-Maturana R
Curr Top Med Chem; 2015; 15(17):1663-72. PubMed ID: 25915614
[TBL] [Abstract][Full Text] [Related]
13. Structural Interactions of Curcumin Biotransformed Molecules with the N-Terminal Residues of Cytotoxic-Associated Gene A Protein Provide Insights into Suppression of Oncogenic Activities.
Srivastava AK; Singh D; Roy BK
Interdiscip Sci; 2017 Mar; 9(1):116-129. PubMed ID: 26798036
[TBL] [Abstract][Full Text] [Related]
14. Curcumin as a potential protective compound against cardiac diseases.
Jiang S; Han J; Li T; Xin Z; Ma Z; Di W; Hu W; Gong B; Di S; Wang D; Yang Y
Pharmacol Res; 2017 May; 119():373-383. PubMed ID: 28274852
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric.
Aggarwal BB; Yuan W; Li S; Gupta SC
Mol Nutr Food Res; 2013 Sep; 57(9):1529-42. PubMed ID: 23847105
[TBL] [Abstract][Full Text] [Related]
16. Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile.
Momtazi AA; Sahebkar A
Curr Pharm Des; 2016; 22(28):4386-97. PubMed ID: 27229723
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and Health.
Pulido-Moran M; Moreno-Fernandez J; Ramirez-Tortosa C; Ramirez-Tortosa M
Molecules; 2016 Feb; 21(3):264. PubMed ID: 26927041
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Biological Studies of New Multifunctional Curcumin Platforms for Anticancer Drug Delivery.
Bazylevich A; Tuchinsky H; Zigman-Hoffman E; Weissman R; Shpilberg O; Hershkovitz-Rokah O; Patsenker L; Gellerman G
Med Chem; 2019; 15(5):537-549. PubMed ID: 30501600
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.
Bayomi SM; El-Kashef HA; El-Ashmawy MB; Nasr MN; El-Sherbeny MA; Abdel-Aziz NI; El-Sayed MA; Suddek GM; El-Messery SM; Ghaly MA
Eur J Med Chem; 2015 Aug; 101():584-94. PubMed ID: 26197162
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease.
Patel SS; Acharya A; Ray RS; Agrawal R; Raghuwanshi R; Jain P
Crit Rev Food Sci Nutr; 2020; 60(6):887-939. PubMed ID: 30632782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
